HIV 1 group M subtype C (isolate 92BR025) Gag 178-185, TPQDLNTML
Description
About HIV 1 group M subtype C (isolate 92BR025) Gag 178-185, TPQDLNTML
The Human immunodeficiency virus (HIV) type 1 group M subtype C (isolate 92BR025) Gag polyprotein (gag) Peptide (IEDB: 102149) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Gag polyprotein (gag) Peptide, H-TPQDLNTML-OH (Uniprot: O12157 aa: 178-185) from JPT is produced under strict quality control and quality management.
HIV 1 group M subtype C (isolate 92BR025) Gag 178-185, TPQDLNTML - Specifications
- Peptide sequence: H-TPQDLNTML-OH
- Amount: 1 mg
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): AIDS (HIV)
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for HIV 1 group M subtype C (isolate 92BR025) Gag 178-185, TPQDLNTML
References:
Read References with JPT’s Antigen Peptides
HIV 1 group M subtype C (isolate 92BR025) Gag 178-185, TPQDLNTML has been described in:
Extensive HLA class I allele promiscuity among viral CTL epitopes., Eur J Immunol, 2007 (PMID: 17705138)
A molecular switch in immunodominant HIV-1-specific CD8 T-cell epitopes shapes differential HLA-restricted escape., Retrovirology, 2015 (PMID: 25808313)
Documentation
Documentation for HIV 1 group M subtype C (isolate 92BR025) Gag 178-185, TPQDLNTML
Properties
Properties of HIV 1 group M subtype C (isolate 92BR025) Gag 178-185, TPQDLNTML
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | AIDS (HIV) |
Layout: | Freeze-dried in glass vial |
Organism: | Human immunodeficiency virus (HIV) |
Protein Name: | Gag polyprotein (gag) |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to HIV 1 group M subtype C (isolate 92BR025) Gag 178-185, TPQDLNTML
Information | Values |
---|---|
Sequence: | H-TPQDLNTML-OH |
Specifications: | 9mer peptide as TFA salt |